Skip to main content
Top
Published in: Diabetologia 6/2016

01-06-2016 | Article

Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study

Authors: I-Ching Chou, Chung-Hsing Wang, Wei-De Lin, Fuu-Jen Tsai, Che-Chen Lin, Chia-Hung Kao

Published in: Diabetologia | Issue 6/2016

Login to get access

Abstract

Aims/hypothesis

Type 1 diabetes mellitus is a major public health problem of increasing global concern, with potential neurological complications. A possible association exists between type 1 diabetes and subsequent epilepsy. This study evaluated the relationship between type 1 diabetes and epilepsy in Taiwan.

Methods

Claims data from the Taiwan National Health Insurance Research Database were used to conduct retrospective cohort analyses. The study cohort contained 2568 patients with type 1 diabetes, each of whom was frequency-matched by sex, urbanisation of residence area and index year with ten patients without type 1 diabetes. Cox proportional hazard regression analysis was conducted to estimate the effects of type 1 diabetes on epilepsy risk.

Results

In patients with type 1 diabetes, the risk of developing epilepsy was significantly higher than that in patients without type 1 diabetes (p < 0.0001 for logrank test). After adjustment for potential confounders, the type 1 diabetes cohort was 2.84 times as likely to develop epilepsy than the control cohort was (HR 2.84 [95% CI 2.11, 3.83]).

Conclusions/interpretation

Patients with type 1 diabetes are at an increased risk of developing epilepsy. Metabolic abnormalities of type 1 diabetes, such as hyperglycaemia and hypoglycaemia, may have a damaging effect on the central nervous system and be associated with significant long-term neurological sequelae. The causative factors between type 1 diabetes and the increased risk of epilepsy require further investigation.
Literature
1.
2.
go back to reference Rawshani A, Landin-Olsson M, Svensson AM et al (2014) The incidence of diabetes among 0–34 year olds in Sweden: new data and better methods. Diabetologia 57:1375–1381CrossRefPubMedPubMedCentral Rawshani A, Landin-Olsson M, Svensson AM et al (2014) The incidence of diabetes among 0–34 year olds in Sweden: new data and better methods. Diabetologia 57:1375–1381CrossRefPubMedPubMedCentral
3.
go back to reference Patterson C, Guariguata L, Dahlquist G, Soltész G, Ogle G, Silink M (2014) Diabetes in the young—a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract 103:161–175CrossRefPubMed Patterson C, Guariguata L, Dahlquist G, Soltész G, Ogle G, Silink M (2014) Diabetes in the young—a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract 103:161–175CrossRefPubMed
5.
go back to reference Kollipara S (2006) Comorbidities associated with type 1 diabetes. School Nurse News 23:42–45PubMed Kollipara S (2006) Comorbidities associated with type 1 diabetes. School Nurse News 23:42–45PubMed
6.
go back to reference Zhao Y, Ye W, Boye KS, Holcombe JH, Swindle R (2009) Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities. Diabet Med 26:61–69CrossRefPubMed Zhao Y, Ye W, Boye KS, Holcombe JH, Swindle R (2009) Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities. Diabet Med 26:61–69CrossRefPubMed
7.
go back to reference Moshè SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet 7:884–898CrossRef Moshè SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet 7:884–898CrossRef
8.
go back to reference Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482CrossRefPubMed Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482CrossRefPubMed
9.
go back to reference Cowan LD (2002) The epidemiology of the epilepsies in children. Ment Retard Dev Disabil Res Rev 8:171–181CrossRefPubMed Cowan LD (2002) The epidemiology of the epilepsies in children. Ment Retard Dev Disabil Res Rev 8:171–181CrossRefPubMed
10.
go back to reference Soltész G, Acsádi G (1989) Association between diabetes, severe hypo-glycaemia, and electroencephalographic abnormalities. Arch Dis Child 64:992–996CrossRefPubMedPubMedCentral Soltész G, Acsádi G (1989) Association between diabetes, severe hypo-glycaemia, and electroencephalographic abnormalities. Arch Dis Child 64:992–996CrossRefPubMedPubMedCentral
11.
go back to reference Bergey GK (2012) Autoantibodies in the patient with drug-resistant epilepsy: are we missing a treatable etiology? Arch Neurol 69:565–566CrossRefPubMed Bergey GK (2012) Autoantibodies in the patient with drug-resistant epilepsy: are we missing a treatable etiology? Arch Neurol 69:565–566CrossRefPubMed
13.
go back to reference McKnight K, Jiang Y, Hart Y et al (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730–1736CrossRefPubMed McKnight K, Jiang Y, Hart Y et al (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730–1736CrossRefPubMed
14.
go back to reference Barajas RF, Collins DE, Cha S, Geschwind MD (2010) Adult-onset drug-refractory seizure disorder associated with anti-voltage–gated potassium-channel antibody. Epilepsia 51:473–477CrossRefPubMedPubMedCentral Barajas RF, Collins DE, Cha S, Geschwind MD (2010) Adult-onset drug-refractory seizure disorder associated with anti-voltage–gated potassium-channel antibody. Epilepsia 51:473–477CrossRefPubMedPubMedCentral
15.
go back to reference Liimatainen S, Peltola M, Sabater L et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760–767CrossRefPubMed Liimatainen S, Peltola M, Sabater L et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760–767CrossRefPubMed
16.
go back to reference Lin JJ, Lin KL, Hsia SH, Wang HS, Chou IJ, Lin YT (2012) CHEESE Study Group. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus. Pediatr Neurol 47:252–258CrossRefPubMed Lin JJ, Lin KL, Hsia SH, Wang HS, Chou IJ, Lin YT (2012) CHEESE Study Group. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus. Pediatr Neurol 47:252–258CrossRefPubMed
17.
go back to reference Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti–NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098CrossRefPubMedPubMedCentral Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti–NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098CrossRefPubMedPubMedCentral
18.
go back to reference McCorry D, Nicolson A, Smith D, Marson A, Feltbower RG, Chadwick DW (2006) An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 59:204–206CrossRefPubMed McCorry D, Nicolson A, Smith D, Marson A, Feltbower RG, Chadwick DW (2006) An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 59:204–206CrossRefPubMed
19.
go back to reference O’Connell MA, Harvey AS, Mackay MT, Cameron FJ (2008) Does epilepsy occur more frequently in children with Type 1 diabetes? J Paediatr Child Health 44:586–589CrossRefPubMed O’Connell MA, Harvey AS, Mackay MT, Cameron FJ (2008) Does epilepsy occur more frequently in children with Type 1 diabetes? J Paediatr Child Health 44:586–589CrossRefPubMed
20.
go back to reference Silverstein J, Klingensmith G, Copeland K et al (2005) Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28:186CrossRefPubMed Silverstein J, Klingensmith G, Copeland K et al (2005) Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28:186CrossRefPubMed
22.
go back to reference Liu CY, Hung YT, Chuang YL et al (2006) Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 14:1–22 Liu CY, Hung YT, Chuang YL et al (2006) Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 14:1–22
23.
go back to reference Yun C, Xuefeng W (2013) Association between seizures and diabetes mellitus: a comprehensive review of literature. Curr Diabetes Rev 9:350–354CrossRefPubMed Yun C, Xuefeng W (2013) Association between seizures and diabetes mellitus: a comprehensive review of literature. Curr Diabetes Rev 9:350–354CrossRefPubMed
24.
go back to reference Maheandiran M, Mylvaganam S, Wu C et al (2013) Severe hypoglycemia in a juvenile diabetic rat model: presence and severity of seizures are associated with mortality. PLoS One 8:e83168CrossRefPubMedPubMedCentral Maheandiran M, Mylvaganam S, Wu C et al (2013) Severe hypoglycemia in a juvenile diabetic rat model: presence and severity of seizures are associated with mortality. PLoS One 8:e83168CrossRefPubMedPubMedCentral
25.
go back to reference Schwechter EM, Velísková J, Velísek L (2003) Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 53:91–101CrossRefPubMed Schwechter EM, Velísková J, Velísek L (2003) Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 53:91–101CrossRefPubMed
26.
go back to reference Kirchner A, Velísková J, Velísek L (2006) Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur J Neurosci 23:1512–1522CrossRefPubMed Kirchner A, Velísková J, Velísek L (2006) Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur J Neurosci 23:1512–1522CrossRefPubMed
27.
28.
go back to reference Striano P, Errichiello L, Striano S (2011) Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance? Epilepsy Behav 20:145PubMed Striano P, Errichiello L, Striano S (2011) Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance? Epilepsy Behav 20:145PubMed
29.
go back to reference Saiz A, Blanco Y, Sabater L et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131:2553–2563CrossRefPubMed Saiz A, Blanco Y, Sabater L et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131:2553–2563CrossRefPubMed
30.
go back to reference Olson JA, Olson DM, Sandborg C, Alexander S, Buckingham B (2002) Type 1 diabetes mellitus and epilepsy partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics 109, E50CrossRefPubMed Olson JA, Olson DM, Sandborg C, Alexander S, Buckingham B (2002) Type 1 diabetes mellitus and epilepsy partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics 109, E50CrossRefPubMed
31.
go back to reference Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726–735CrossRefPubMed Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726–735CrossRefPubMed
32.
go back to reference Desrocher M, Rovet J (2004) Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol 10:36–52CrossRefPubMed Desrocher M, Rovet J (2004) Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol 10:36–52CrossRefPubMed
33.
go back to reference Northam EA, Rankins D, Cameron FJ (2006) Therapy insight: the impact of type 1 diabetes on brain development and function. Nat Clin Pract Neurol 2:78–86CrossRefPubMed Northam EA, Rankins D, Cameron FJ (2006) Therapy insight: the impact of type 1 diabetes on brain development and function. Nat Clin Pract Neurol 2:78–86CrossRefPubMed
34.
go back to reference Knight S, Northam E, Donath S et al (2009) Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study. Diabetologia 52:193–198CrossRefPubMed Knight S, Northam E, Donath S et al (2009) Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study. Diabetologia 52:193–198CrossRefPubMed
35.
go back to reference Wayne EA, Dean HJ, Booth F, Tenenbein M (1990) Focal neurological deficits associated with hypoglycemia in children with diabetes. J Pediatr 117:575–577CrossRefPubMed Wayne EA, Dean HJ, Booth F, Tenenbein M (1990) Focal neurological deficits associated with hypoglycemia in children with diabetes. J Pediatr 117:575–577CrossRefPubMed
36.
go back to reference Lahat E, Barr J, Bistritzer T (1995) Focal epileptic episodes associated with hypoglycemia in children with diabetes. Clin Neurol Neurosurg 97:314–316CrossRefPubMed Lahat E, Barr J, Bistritzer T (1995) Focal epileptic episodes associated with hypoglycemia in children with diabetes. Clin Neurol Neurosurg 97:314–316CrossRefPubMed
37.
go back to reference Home P, Haddad J, Latif ZA et al (2013) Comparison of national/regional diabetes guidelines for the management of blood glucose control in non-Western Countries. Diabetes Ther 4:91–102CrossRefPubMedPubMedCentral Home P, Haddad J, Latif ZA et al (2013) Comparison of national/regional diabetes guidelines for the management of blood glucose control in non-Western Countries. Diabetes Ther 4:91–102CrossRefPubMedPubMedCentral
Metadata
Title
Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study
Authors
I-Ching Chou
Chung-Hsing Wang
Wei-De Lin
Fuu-Jen Tsai
Che-Chen Lin
Chia-Hung Kao
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 6/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-3929-0

Other articles of this Issue 6/2016

Diabetologia 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.